Download PDF
Deutsche Zeitschrift für Onkologie 2016; 48(03): 120-125
DOI: 10.1055/s-0042-113495
Praxis
© Karl F. Haug Verlag in MVS Medizinverlage Stuttgart GmbH & Co. KG

Anwendung von Helleborus niger bei individueller integrativer Therapie eines metastasierten Mammakarzinoms mit Pleuraerguss

Friedrich Migeod
,
Vera Kneer
Further Information

Publication History

Publication Date:
05 October 2016 (online)

    Permissions and Reprints

Zusammenfassung

In dieser Fallbeschreibung wird ein individuelles integratives Behandlungskonzept bei einer palliativen Patientin mit metastasiertem Mammakarzinom vorgestellt. Im Mittelpunkt steht dabei Helleborus niger (Christrose), eine in der komplementären Onkologie bisher wenig beachtete Heilpflanze. Im vorliegenden Fall wurde Helleborus niger D12 in Form von täglichen Kaltinhalationen zunächst zur symptomatischen Behandlung von Dyspnoe und Reizhusten bei Pleuraerguss eingesetzt. Darüber hinaus verabreichten wir täglich subkutane Injektionen zur Immunmodulation wie auch zur Unterstützung der Diurese. In Kombination mit anderen komplementären Therapieprinzipien ließen sich zusätzlich gute Effekte hinsichtlich Kachexie, Muskelabbau, Schlaflosigkeit, Angst und Unruhe erzielen, die alle palliativmedizinisch relevant sind. Dabei waren weder Nebenwirkungen noch Wechselwirkungen mit chemischen oder pflanzlichen Stoffen zu verzeichnen. Nach 9-monatiger Therapie war klinisch wie sonografisch kein Pleuraerguss mehr nachweisbar. Auch die übrigen Tumormanifestationen befanden sich in Regression, was mit einer deutlichen Stabilisierung der Patientin und Verbesserung ihrer Lebensqualität einherging. Es lohnt daher, Helleborus niger in integrative Behandlungskonzepte aufzunehmen und durch breiteren klinischen Einsatz weitere Wirkmechanismen zu eruieren.

Summary

The case report presents an individual integrative therapeutic approach in palliative breast cancer. The focus is on Hellebore niger (Christrose), a herbal formula that has received little attention in complementary oncology so far. We used Hellebore niger D12 in form of daily cold inhalations for dyspnea and dry coughs caused by pleural effusion and administered D12 injections s. c. for immunmodulation and diuretic effects. In combination with complementary and conventional therapies we also achieved good results as to cachexia, loss of muscles, sleeplessness, reduction of fear and restlessness that are common problems in palliative care. Very important is to see that there were no side effects or interactions with other therapies. After 9 months of complex integrative program the pleural effusion could no longer be detected and all other tumor manifestations were in regression. The multiple positive effects of Hellebore niger in concert with the other therapies did not only improve the life quality of the patient but also lead to impressive treatment effects. It is therefore worthwhile to include Hellebore niger in complementary concepts and to study further its broad active profile.

Schlüsselwörter

Mammakarzinom - Pleuraerguss - integrative Therapie - palliative Therapie - Helleborus niger

Keywords

Breast cancer - pleural effusion - integrative therapy - palliative therapy - helleborus niger
 

  • Literatur

  • 1 Arafa H. Uroprotective effects of Curcumin in Cyclophosphamide induced haemorrhagic cystitis paradigm. Bas Clin Pharmacol Toxicol 2009; 104(5): 393-9
    CrossrefPubMedGoogle Scholar
  • 2 Baker KM, Bauer AC. Green tea catechin, EGCG, suppresses PCP 102-induced proliferation in Estrogen sensitive breast cancer cells. Int J Breast Cancer 2015; 11: 1-7
    PubMedGoogle Scholar
  • 3 Banys-Paluchowski M, Schütz F et al. Metronomic Chemotherapy for Metastatic Breast Cancer – a Systematic Review of Literature – eine systematische Literaturrecherche. Geburtshilfe Frauenheilk 2016; 76(5): 525-534
    Article in Thieme ConnectPubMedGoogle Scholar
  • 4 Ben Arye E, Schiff E. Integrative oncology in the Middle East: from traditional herbal knowledge to contemporary cancer care. Ann Oncol 2012; 23 (1): 211-21
    CrossrefPubMedGoogle Scholar
  • 5 Breitkreuz T. Helleborus niger in der Onkologie. Kasuistiken und Therapieerfahrungen aus dem Gemeinschaftskrankenhaus Herdecke 2001–2010. Merkurstab 2010; Heft 6: 526-534
    PubMedGoogle Scholar
  • 6 Büssing A, Schweizer K. Effects of a phytopreparation from Helleborus niger on immunocompetent cells in vitro. J Ethnopharmacol 1998; 59: 139-46
    CrossrefPubMedGoogle Scholar
  • 7 Dai Y, Hogan S et al. Selective growth inhibition of human breast cancer cells by graviola fruit extract in vitro and in vivo involving downregulation of EGFR expression. Nutr Cancer 2011; 63(5): 795-801
    CrossrefPubMedGoogle Scholar
  • 8 Delebinski C et al. A root extract of Helleborus niger posses cytotoxic properties in neuroblastoma cells. BMC Complement Alternat Med 2012; 12 (Suppl 1): 16
    PubMedGoogle Scholar
  • 9 Duckstein SM, Stintzing FC. Comprehensive study of the phenolics and saponins from Helleborus niger L. Chem Biodiver 2014; 11: 276-98
    CrossrefPubMedGoogle Scholar
  • 10 Duckstein SM, Stintzing FC. LC-MS(n) characterization of steroidal saponins in Helleborus niger L. roots and their conversion products during fermentation. Steroids 2015; 93: 47-59
    CrossrefPubMedGoogle Scholar
  • 11 Emami SA, Sahebkar A et al. Cancer and its treatment in main ancient book of Islamic Iranian traditional medicine (7th to 14th century AD). Iran Red Crescent Med J 2012; 14 (12): 747-57
    CrossrefPubMedGoogle Scholar
  • 12 Fernandes AP, Gandin V. Selenium compounds as therapeutic agents in cancer. Biochim Biophys Acta 2015; 1850 (8): 1642-60
    CrossrefPubMedGoogle Scholar
  • 13 Feuerecker B, Pirsig S et al. Lipoic acid inhibit cell proliferation of tumor cells in vitro and in vivo. Cancer Biol Ther 2012; 13(14): 1425-35
    CrossrefPubMedGoogle Scholar
  • 14 Gröber U, Kisters K, Spitz J. Adamietz I-A. Vitamin D in der onkologischen Intervention: Update 2015. Dtsch Z Onkol 2015; 47(4): 173-77
    PubMedGoogle Scholar
  • 15 Harms W, Budach W et al. Review Article DEGRO-Leitlinien für die Strahlentherapie des Mammakarzinoms VI: Therapie lokoregionaler Mammakarzinomrezidive. Strahlenther Onkol 2016; 192(4): 199-208
    CrossrefPubMedGoogle Scholar
  • 16 Kotecha R, Takami A et al. Dietary phytochemicals and cancer chemoprevention: a review of clinical evidence. Oncotarget 2016, May 25 [epub].
    PubMedGoogle Scholar
  • 17 Jeong Y, Swami S et al. Inhibition of mouse breast tumor-initiating cells by Calcitriol and dietary Vitamin D. Mol Cancer Ther 2015; 14(8): 1951-61
    CrossrefPubMedGoogle Scholar
  • 18 Jesse P, Mottke G et al. Apoptosis induced by extracts of helleborus niger in different lymphoma and leukaemia cell lines and primary lymphoblasts of children with ALL. Pediatr Blood Cancer 2009; 52 (4): 464-69
    CrossrefPubMedGoogle Scholar
  • 19 Joeng CH, Joo SH. Downregulation of reactive Oxygen species in apoptosis. J Cancer Prev 2016; 21 (1): 13-20
    PubMedGoogle Scholar
  • 20 Levitsky DO, Dembitsky VM. Anti-breast cancer agents derived from plants. Nat Prod Bioprospect 2015; 5(1): 1-16
    CrossrefPubMedGoogle Scholar
  • 21 Maior MC, Dobrota C. Natural compunds with important medical potential found in Helleborus sp. Cent Eur J Biol 2013; 8(3): 272-85
    PubMedGoogle Scholar
  • 22 Münstedt K, Männle H. Grüner Tee zur primären und tertiären Prophylaxe des Mammakarzinoms. Dtsch Z Onkol 2015; 47(1): 10-12
    PubMedGoogle Scholar
  • 23 Moghadamtousi SZ, Fadaeinasab M et al. Annona muricata (Annonaceae): A Review of Its Traditional Uses, Isolated Acetogenins and Biological Activities. Int J Mol Sci 2015; 16(7): 15625-1558
    CrossrefPubMedGoogle Scholar
  • 24 Oei AL, Vriend LE et al. Effects of hyperthermia on DNA repair pathways: one treatment to inhibit them all. Radiat Oncol 2015; 10: 165
    CrossrefPubMedGoogle Scholar
  • 25 Pantziarka G et al. Repurposing drugs in oncology (ReDO) – Cimetidine as an anti-cancer agent. Ecancermedicalscience 2014; 8: 485
    PubMedGoogle Scholar
  • 26 Patel PB, Thakkar VR et al. Cellular effect of Curcumin and citral combination on breast cancer cells: induction of apoptosis and cell cycle arrest. J Breast Cancer 2015; 18(3): 225-334
    CrossrefPubMedGoogle Scholar
  • 27 Perroud HA, Alasino CM. Metastatic breast cancer patients treated with low-dose metronomic chemotherapy with cyclophophamide and celecoxib: clinical outcomes and biomarkers of response. Cancer Chemother Pharmacol 2016; 77(2): 365-74
    CrossrefPubMedGoogle Scholar
  • 28 Perroud HA, Rico MJ, Alasino CM et al. Association between baseline VEGF/sVEGFR-2 and VEGF/TSP-1 ratios and response to metronomic chemotherapy using cyclophosphamide and celecoxib in patients with advanced breast cancer. Indian J Cancer 2013; 50(2): 115-21
    CrossrefPubMedGoogle Scholar
  • 29 Perroud HA Alasino, et al. Quality of life in patients with metastatic breast cancer treated with metronomic chemotherapy. Future Oncol 2016; 12(10): 1233-42
    CrossrefPubMedGoogle Scholar
  • 30 Pfeifer BL, Fahrendorf T. Indol-3-Carbinol – ein Glucosinulat-Derivat aus Kreuzblütler-Gemüsen zur Vorbeugung und komplementär-onkologischen Behandlung von Brustkrebs. Dtsch Z Onkol 2015; 47(1): 20-7
    PubMedGoogle Scholar
  • 31 Pirouzpanah MB, Sabzichi M et al. Silibilin-induces apoptosis in breast cancer cells by modulating p53, p21, Bak and Bcl-XL pathways. Asian Pac J Cancer Prev 2015; 16(5): 2087-92
    CrossrefPubMedGoogle Scholar
  • 32 Romiti A, Cox MC et al. Metronomic chemotherapy for cancer treatment: a decade of clinical studies. Cancer Chemother Pharmacol 2013; 72(1): 13-33
    CrossrefPubMedGoogle Scholar
  • 33 Schäfer D. Old Age and Disease in Early Modern Medicine. London: Pickering & Chatto; 2011
    Google Scholar
  • 34 Schink M, Garcia-Käufer M et al. Differential cytotoxic properties of Helleborus niger L on tumour and immunocompetent cells. J Ethnopharmacol 2015; 159: 129-36
    CrossrefPubMedGoogle Scholar
  • 35 Seidlova-Wuttke D, Christel D et al. Beta-ecdysone has bone protective but no estrogenic effects in ovariectomized rats. Phytomedicine 2010; 17(11): 884-9
    CrossrefPubMedGoogle Scholar
  • 36 Seifert G, Budach V et al. Regional hyperthermia combined with chemotherapy in paediatric, adolescent and young adult patients: current and future perspectives. Radiat Oncol 2016; 11(1): 65
    CrossrefPubMedGoogle Scholar
  • 37 Sidhu JS, Singla R et al. Indole Derivatives as Anticancer Agents for Breast Cancer Therapy: A Review. Anticancer Agents Med Chem 2015; 16(2): 160-73
    CrossrefPubMedGoogle Scholar
  • 38 Skuse A. Chapter 5: Wolves Tongues and Mercury. Pharmaceutical Cure for Cancer. In: Skuse A. Constructions of Cancer in Early Modern England. Basingstoke: Palgrave Macmillan; 2015
    CrossrefGoogle Scholar
  • 39 Srivastava S, Somasagara RR et al. Quercetin, a natural flavonoid interacts with DNA, arrests cell cycle and causes tumor regression by activating mitochondrial pathway of apoptosis. Sci Rep 2016; 6: 240-49
    PubMedGoogle Scholar
  • 40 Thomson CA, HO E, Strom MB. Chemopreventive properties of 3,3’ diindolylmethane in breast cancer: evidence from experimental and human studies. See comment in PubMed Commons below. Nutr Rev 2016; 74(7): 432-43
    CrossrefPubMedGoogle Scholar
  • 41 van den Tempel N, Horsman R. Improving efficacy of hyperthermia in oncology by exploiting mechanisms. Int J Hyperthermia 2016; 18: 1-9
    PubMedGoogle Scholar
  • 42 Velasco G, Sanchez C et al. Anticancer mechanisms of cannabinoids. Curr Oncol 2016; 23(2): 23-32
    CrossrefPubMedGoogle Scholar
  • 43 Wilkens J. Die Heilkraft der Christrose. Aarau: AT Verlag; 2014
    Google Scholar
  • 44 Yoshimoto M, Takao S et al. Metronomic oral combination chemotherapy with capecitabine and cyclophophamide: a phase II study in patients with HER-2 negative metastatic breast cancer. See comment in PubMed Commons below. Cancer Chemother Pharmacol 2012; 70(2): 331-8
    CrossrefPubMedGoogle Scholar
  • 45 Zheng N, Liu L et al. ERβ up-regulation was involved in silibinin-induced growth inhibition of human breast cancer MCF-7 cells. Arch Biochem Biophys 2016; 591: 141-9
    CrossrefPubMedGoogle Scholar
  • 46 Zhou X, Wang W, Li P, Zheng Z, Tu Y, Zhang Y, You T. Curcumin enhances the effects of 5-fluorouracil and oxaliplatin in inducing gastric cancer cell apoptosis both in vitro and in vivo. Oncol Res 2016; 23(1–2): 29-34
    CrossrefPubMedGoogle Scholar